Your browser doesn't support javascript.
loading
Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent.
Jung, Minsun; Lee, Kyung-Min; Im, Yebin; Seok, Seung Hyeok; Chung, Hyewon; Kim, Da Young; Han, Dohyun; Lee, Cheng Hyun; Hwang, Eun Hye; Park, Soo Young; Koh, Jiwon; Kim, Bohyun; Nikas, Ilias P; Lee, Hyebin; Hwang, Daehee; Ryu, Han Suk.
Affiliation
  • Jung M; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Lee KM; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Im Y; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Seok SH; School of Biological Sciences, Seoul National University, Seoul, Korea.
  • Chung H; Department of Microbiology and Immunology and Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
  • Kim DY; Department of Microbiology and Immunology and Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
  • Han D; Department of Microbiology and Immunology and Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
  • Lee CH; Proteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Hwang EH; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Park SY; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Koh J; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Kim B; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Nikas IP; Department of Pathology, Seoul National University Hospital, Seoul, Korea.
  • Lee H; Department of Pathology, Seoul National University Hospital, Seoul, Korea.
  • Hwang D; Department of Pathology, Seoul National University Hospital, Seoul, Korea.
  • Ryu HS; School of Medicine, European University Cyprus, Nicosia, Cyprus.
Mol Oncol ; 16(9): 1795-1815, 2022 05.
Article in En | MEDLINE | ID: mdl-35278276
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms / Niacin Limits: Animals / Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms / Niacin Limits: Animals / Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Document type: Article